L. Merle

709 total citations
31 papers, 543 citations indexed

About

L. Merle is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, L. Merle has authored 31 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Geriatrics and Gerontology. Recurrent topics in L. Merle's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Analytical Chemistry and Chromatography (4 papers) and Metabolism and Genetic Disorders (3 papers). L. Merle is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Analytical Chemistry and Chromatography (4 papers) and Metabolism and Genetic Disorders (3 papers). L. Merle collaborates with scholars based in France and United States. L. Merle's co-authors include Marie‐Laure Laroche, Gérard Lachâtre, Pierre Marquet, J.P. Charmes, Thierry Dantoine, C Leroux-Robert, Jean Debord, Christophe Sabot, Alain Colvez and Joanny Moulin and has published in prestigious journals such as Journal of the American Society of Nephrology, Cellular and Molecular Life Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

L. Merle

31 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Merle France 10 174 118 96 86 64 31 543
Anthony P. Morreale United States 18 285 1.6× 34 0.3× 142 1.5× 138 1.6× 148 2.3× 61 1.1k
Arthur A. Schuna United States 13 49 0.3× 39 0.3× 85 0.9× 40 0.5× 33 0.5× 19 573
Soha Namazi Iran 16 150 0.9× 38 0.3× 165 1.7× 46 0.5× 210 3.3× 63 1.3k
Ghazal Vessal Iran 11 94 0.5× 37 0.3× 76 0.8× 36 0.4× 132 2.1× 11 541
Surakit Nathisuwan Thailand 19 108 0.6× 24 0.2× 120 1.3× 107 1.2× 125 2.0× 72 1.2k
Chi‐Chuan Wang Taiwan 16 59 0.3× 17 0.1× 122 1.3× 55 0.6× 70 1.1× 73 821
Pim N.J. Langendijk Netherlands 16 122 0.7× 31 0.3× 242 2.5× 22 0.3× 124 1.9× 25 1.1k
Lisa L. Ioannides‐Demos Australia 16 43 0.2× 27 0.2× 371 3.9× 91 1.1× 72 1.1× 36 945
A. Pannatier Switzerland 12 113 0.6× 20 0.2× 85 0.9× 19 0.2× 42 0.7× 28 595
P. K. M. Lunde Norway 24 76 0.4× 77 0.7× 165 1.7× 68 0.8× 146 2.3× 52 1.3k

Countries citing papers authored by L. Merle

Since Specialization
Citations

This map shows the geographic impact of L. Merle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Merle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Merle more than expected).

Fields of papers citing papers by L. Merle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Merle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Merle. The network helps show where L. Merle may publish in the future.

Co-authorship network of co-authors of L. Merle

This figure shows the co-authorship network connecting the top 25 collaborators of L. Merle. A scholar is included among the top collaborators of L. Merle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Merle. L. Merle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bongué, Bienvenu, Marie‐Laure Laroche, Alain Colvez, et al.. (2011). Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. European Journal of Clinical Pharmacology. 67(12). 1291–1299. 58 indexed citations
2.
Laroche, Marie‐Laure, et al.. (2009). Response to “Inappropriate Medications and Adverse Drug Reactions in the Elderly”. Clinical Pharmacology & Therapeutics. 85(5). 472–473. 1 indexed citations
3.
Laroche, Marie‐Laure, et al.. (2008). Inappropriate Medications in the Elderly. Clinical Pharmacology & Therapeutics. 85(1). 94–97. 81 indexed citations
4.
Laroche, Marie‐Laure, et al.. (2008). Médicaments potentiellement inappropriés aux personnes âgées : intérêt d’une liste adaptée à la pratique médicale française. La Revue de Médecine Interne. 30(7). 592–601. 59 indexed citations
5.
Laroche, Marie‐Laure & L. Merle. (2006). GENERIC AND BRAND-NAME DRUGS. ARE DIFFERENT CRITERIA SUFFICIENTLY TAKEN INTO ACCOUNT BEFORE GRANTING MARKET AUTHORISATION?. Acta Clinica Belgica. 61(sup1). 46–48. 1 indexed citations
6.
Dantoine, Thierry, Jean Debord, L. Merle, & J.P. Charmes. (2003). De l’intoxication par les composés organophosphorés à l’athérosclérose : rôles de la paraoxonase 1. La Revue de Médecine Interne. 24(7). 436–442. 13 indexed citations
7.
Sabot, Christophe, et al.. (1998). Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients. European Journal of Clinical Pharmacology. 54(2). 171–175. 24 indexed citations
8.
Dantoine, Thierry, J.P. Charmes, L. Merle, et al.. (1998). Decrease of serum paraoxonase activity in chronic renal failure.. Journal of the American Society of Nephrology. 9(11). 2082–2088. 160 indexed citations
9.
Lotfi, Hayat, et al.. (1996). A Screening Procedure for the Determination of 13 Oral Anticoagulants and Rodenticides. Journal of Analytical Toxicology. 20(2). 93–100. 16 indexed citations
10.
Debord, Jean, et al.. (1995). Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm. Fundamental and Clinical Pharmacology. 9(1). 57–61. 17 indexed citations
11.
Sabot, Christophe, Jean Debord, Bernard Roullet, et al.. (1993). Bayesian Estimation and Population Pharmacokinetic Parameters of High Dose Methotrexate in Osteosarcoma. Clinical Research and Regulatory Affairs. 10(4). 233–241. 8 indexed citations
12.
Merle, L., et al.. (1989). [Importance of urinary enzymes in the monitoring of drug nephrotoxicity].. PubMed. 43(5). 417–8. 1 indexed citations
13.
Nouaille, Yves, et al.. (1987). Problèmes posés par la prescription des tétracyclines durant les premières années de vie. La Revue de Médecine Interne. 8(2). 218–222. 3 indexed citations
14.
Lachâtre, Gérard, et al.. (1984). [Plasma assay of phenobarbital, pentobarbital and penthiobarbital by high performance liquid chromatography].. PubMed. 39(4). 361–7. 5 indexed citations
15.
Lachâtre, Gérard, C. Gonnet, J. L. Rocca, et al.. (1983). High-performance liquid chromatographic method for the determination of bamifylline and its three metabolites in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 277. 239–249. 5 indexed citations
16.
Rocca, J. L., et al.. (1982). Determination of Plasma Norepinephrine and Epinephrine by High Performance Liquid Chromatography Using a Two-Column System and an Electrochemical Detector. Journal of Liquid Chromatography. 5(10). 1947–1965. 6 indexed citations
17.
Merle, L., et al.. (1981). [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].. PubMed. 36(1). 55–64. 2 indexed citations
18.
Merle, L., et al.. (1979). [Hypertensive attack during treatment with indomethacin: role of the sympathetic nervous system].. PubMed. 8(27). 2283–2283. 3 indexed citations
19.
Merle, L., et al.. (1978). [Problems related to the use of anesthetic eye-lotions and creams in ophthalmology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(6). 791–5. 2 indexed citations
20.
Merle, L., et al.. (1978). Effect of food and light schedule on bile flow in the rat. Cellular and Molecular Life Sciences. 34(6). 764–765. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026